COVID-19-associated coagulopathy and antithrombotic agentslessons after 1 year, The Lancet Haematology

Article summarises pathophysiology of COVID-19 coagulopathy in the context of patients who are ambulant, admitted to hospital, and critically or non-critically ill, and those post-discharge. It reviews data from RCTs of antithrombotic therapy in patients who are critically ill.

Source: Current Awareness Service for Health (CASH) - April 29, 2021 Category: Consumer Health News Source Type: news